Trial Outcomes & Findings for Total Shoulder Arthroplasty Near-infrared Spectroscopy (NCT NCT02198183)
NCT ID: NCT02198183
Last Updated: 2023-01-17
Results Overview
The number of Cerebral Desaturation Events (CDE) that occured. CDE is defined as a reduction in cerebral tissue oxygen saturation of \>20% from baseline that lasts for 90 seconds or longer.
COMPLETED
34 participants
Day of surgery
2023-01-17
Participant Flow
Participant milestones
| Measure |
Near-infrared Spectroscopy
Casmed Fore-Sight Elite and Non-invasive Cardiac Output Monitor (NICOM)
Casmed Fore-Sight Elite
Non-invasive Cardiac Output Monitor (NICOM)
|
|---|---|
|
Overall Study
STARTED
|
34
|
|
Overall Study
COMPLETED
|
25
|
|
Overall Study
NOT COMPLETED
|
9
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Total Shoulder Arthroplasty Near-infrared Spectroscopy
Baseline characteristics by cohort
| Measure |
Near-infrared Spectroscopy
n=25 Participants
Casmed Fore-Sight Elite and Non-invasive Cardiac Output Monitor (NICOM)
Casmed Fore-Sight Elite
Non-invasive Cardiac Output Monitor (NICOM)
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=99 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
8 Participants
n=99 Participants
|
|
Age, Categorical
>=65 years
|
17 Participants
n=99 Participants
|
|
Age, Continuous
|
67 years
STANDARD_DEVIATION 8 • n=99 Participants
|
|
Sex: Female, Male
Female
|
11 Participants
n=99 Participants
|
|
Sex: Female, Male
Male
|
14 Participants
n=99 Participants
|
|
Region of Enrollment
United States
|
25 participants
n=99 Participants
|
PRIMARY outcome
Timeframe: Day of surgeryThe number of Cerebral Desaturation Events (CDE) that occured. CDE is defined as a reduction in cerebral tissue oxygen saturation of \>20% from baseline that lasts for 90 seconds or longer.
Outcome measures
| Measure |
Near-infrared Spectroscopy
n=25 Participants
Casmed Fore-Sight Elite and Non-invasive Cardiac Output Monitor (NICOM)
Casmed Fore-Sight Elite
Non-invasive Cardiac Output Monitor (NICOM)
|
|---|---|
|
Number of Cerebral Desaturation Events
|
0 Number of CDE Incidences
|
SECONDARY outcome
Timeframe: Day of surgeryCardiac output of patients as measured in liters per minute
Outcome measures
| Measure |
Near-infrared Spectroscopy
n=25 Participants
Casmed Fore-Sight Elite and Non-invasive Cardiac Output Monitor (NICOM)
Casmed Fore-Sight Elite
Non-invasive Cardiac Output Monitor (NICOM)
|
|---|---|
|
Cardiac Output (CO)
|
5.6 liters per minute
Standard Deviation 1.2
|
SECONDARY outcome
Timeframe: Day of surgeryAverage cardiac index for patients, a measurement of how efficient the heart is pumping. Measured in liters per minute per meters squared of heart size.
Outcome measures
| Measure |
Near-infrared Spectroscopy
n=25 Participants
Casmed Fore-Sight Elite and Non-invasive Cardiac Output Monitor (NICOM)
Casmed Fore-Sight Elite
Non-invasive Cardiac Output Monitor (NICOM)
|
|---|---|
|
Cardiac Index (CI)
|
3 L/min/m^2
Standard Deviation 0.5
|
SECONDARY outcome
Timeframe: Day of surgeryStroke volume, the amount of blood pumped by the left ventricle of the heart with each contraction. Measured in milliliters.
Outcome measures
| Measure |
Near-infrared Spectroscopy
n=25 Participants
Casmed Fore-Sight Elite and Non-invasive Cardiac Output Monitor (NICOM)
Casmed Fore-Sight Elite
Non-invasive Cardiac Output Monitor (NICOM)
|
|---|---|
|
Stroke Volume (SV)
|
74 milliliters
Standard Deviation 11
|
SECONDARY outcome
Timeframe: Day of surgerymean arterial pressure and noninvasive blood pressure will be represented as a percentage of baseline after surgery. A lower percentage is a worse outcome.
Outcome measures
| Measure |
Near-infrared Spectroscopy
n=25 Participants
Casmed Fore-Sight Elite and Non-invasive Cardiac Output Monitor (NICOM)
Casmed Fore-Sight Elite
Non-invasive Cardiac Output Monitor (NICOM)
|
|---|---|
|
Mean Arterial Pressure (MAP)
GA without PPV
|
76 percent
Standard Deviation 15
|
|
Mean Arterial Pressure (MAP)
GA with PPV
|
67 percent
Standard Deviation 17
|
SECONDARY outcome
Timeframe: Day of surgerya lower score is a better outcome.
Outcome measures
| Measure |
Near-infrared Spectroscopy
n=25 Participants
Casmed Fore-Sight Elite and Non-invasive Cardiac Output Monitor (NICOM)
Casmed Fore-Sight Elite
Non-invasive Cardiac Output Monitor (NICOM)
|
|---|---|
|
End Tidal Carbon Dioxide (ETCO2)
GA without PPV
|
44 mmHg
Standard Deviation 5
|
|
End Tidal Carbon Dioxide (ETCO2)
GA with PPV
|
45 mmHg
Standard Deviation 6
|
SECONDARY outcome
Timeframe: Day of surgeryOutcome measures
| Measure |
Near-infrared Spectroscopy
n=25 Participants
Casmed Fore-Sight Elite and Non-invasive Cardiac Output Monitor (NICOM)
Casmed Fore-Sight Elite
Non-invasive Cardiac Output Monitor (NICOM)
|
|---|---|
|
Intravenous Fluid Volume
|
1408 mL
Standard Deviation 227
|
Adverse Events
Near-infrared Spectroscopy
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Dr Jacques Yadeau
Hospital for Special Surgery, Anesthesiology
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place